230 related articles for article (PubMed ID: 27010507)
1. From amino acid sequence to bioactivity: The biomedical potential of antitumor peptides.
Blanco-Míguez A; Gutiérrez-Jácome A; Pérez-Pérez M; Pérez-Rodríguez G; Catalán-García S; Fdez-Riverola F; Lourenço A; Sánchez B
Protein Sci; 2016 Jun; 25(6):1084-95. PubMed ID: 27010507
[TBL] [Abstract][Full Text] [Related]
2. Dual-function synthetic peptide derived from BMP4 for highly efficient tumor targeting and antiangiogenesis.
Choi SH; Lee JY; Suh JS; Park YS; Chung CP; Park YJ
Int J Nanomedicine; 2016; 11():4643-4656. PubMed ID: 27695323
[TBL] [Abstract][Full Text] [Related]
3. CancerPPD: a database of anticancer peptides and proteins.
Tyagi A; Tuknait A; Anand P; Gupta S; Sharma M; Mathur D; Joshi A; Singh S; Gautam A; Raghava GP
Nucleic Acids Res; 2015 Jan; 43(Database issue):D837-43. PubMed ID: 25270878
[TBL] [Abstract][Full Text] [Related]
4. Collagen IV and CXC chemokine-derived antiangiogenic peptides suppress glioma xenograft growth.
Rosca EV; Lal B; Koskimaki JE; Popel AS; Laterra J
Anticancer Drugs; 2012 Aug; 23(7):706-12. PubMed ID: 22495619
[TBL] [Abstract][Full Text] [Related]
5. RK1, the first very short peptide from Buthus occitanus tunetanus inhibits tumor cell migration, proliferation and angiogenesis.
Khamessi O; Ben Mabrouk H; ElFessi-Magouri R; Kharrat R
Biochem Biophys Res Commun; 2018 Apr; 499(1):1-7. PubMed ID: 29366787
[TBL] [Abstract][Full Text] [Related]
6. L-5F, an apolipoprotein A-I mimetic, inhibits tumor angiogenesis by suppressing VEGF/basic FGF signaling pathways.
Gao F; Vasquez SX; Su F; Roberts S; Shah N; Grijalva V; Imaizumi S; Chattopadhyay A; Ganapathy E; Meriwether D; Johnston B; Anantharamaiah GM; Navab M; Fogelman AM; Reddy ST; Farias-Eisner R
Integr Biol (Camb); 2011 Apr; 3(4):479-89. PubMed ID: 21283904
[TBL] [Abstract][Full Text] [Related]
7. Therapeutic potential of capillary morphogenesis gene 2 extracellular vWA domain in tumour‑related angiogenesis.
Ye L; Sun PH; Sanders AJ; Martin TA; Lane J; Mason MD; Jiang WG
Int J Oncol; 2014 Oct; 45(4):1565-73. PubMed ID: 24993339
[TBL] [Abstract][Full Text] [Related]
8. Oridonin inhibits tumor growth and metastasis through anti-angiogenesis by blocking the Notch signaling.
Dong Y; Zhang T; Li J; Deng H; Song Y; Zhai D; Peng Y; Lu X; Liu M; Zhao Y; Yi Z
PLoS One; 2014; 9(12):e113830. PubMed ID: 25485753
[TBL] [Abstract][Full Text] [Related]
9. Development of peptides as potential drugs for cancer therapy.
Li ZJ; Cho CH
Curr Pharm Des; 2010; 16(10):1180-9. PubMed ID: 20166989
[TBL] [Abstract][Full Text] [Related]
10. Preclinical Evidence on the Anticancer Properties of Food Peptides.
Rajendran SR; Ejike CE; Gong M; Hannah W; Udenigwe CC
Protein Pept Lett; 2017; 24(2):126-136. PubMed ID: 27538700
[TBL] [Abstract][Full Text] [Related]
11. Oleanolic Acid Inhibits Colorectal Cancer Angiogenesis by Blocking the VEGFR2 Signaling Pathway.
Niu G; Sun L; Pei Y; Wang D
Anticancer Agents Med Chem; 2018; 18(4):583-590. PubMed ID: 29065844
[TBL] [Abstract][Full Text] [Related]
12. Peptide-Conjugated Nanoparticles as Targeted Anti-angiogenesis Therapeutic and Diagnostic in Cancer.
Rajabi M; Adeyeye M; Mousa SA
Curr Med Chem; 2019; 26(30):5664-5683. PubMed ID: 31250748
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and Screening of Pro-apoptotic and Angio-inhibitory Activity of Novel Benzisoxazole Derivatives both In Vitro and In Vivo.
Byrappa S; Rachaiah K; Kotian SY; Balaraju Y; Prabhuswamimath SC; Rai KML; Salimath BP
Anticancer Agents Med Chem; 2019; 19(6):827-839. PubMed ID: 30648522
[TBL] [Abstract][Full Text] [Related]
14. A novel FGFR1-binding peptide exhibits anti-tumor effect on lung cancer by inhibiting proliferation and angiogenesis.
Tan Q; Wang Z; Wang Q; Wang Y; Huang Z; Su N; Jin M; Kuang L; Qi H; Ni Z; Li C; Zhu Y; Jiang W; Chen H; Deng C; Du X; Xie Y; Chen L
Int J Biol Sci; 2018; 14(10):1389-1398. PubMed ID: 30123084
[TBL] [Abstract][Full Text] [Related]
15. Studies of the antitumor mechanism of action of dermaseptin B2, a multifunctional cationic antimicrobial peptide, reveal a partial implication of cell surface glycosaminoglycans.
Dos Santos C; Hamadat S; Le Saux K; Newton C; Mazouni M; Zargarian L; Miro-Padovani M; Zadigue P; Delbé J; Hamma-Kourbali Y; Amiche M
PLoS One; 2017; 12(8):e0182926. PubMed ID: 28797092
[TBL] [Abstract][Full Text] [Related]
16. Anti-tumor angiogenesis effect of a new compound: B-9-3 through interference with VEGFR2 signaling.
Ma Q; Chen W; Chen W
Tumour Biol; 2016 May; 37(5):6107-16. PubMed ID: 26611645
[TBL] [Abstract][Full Text] [Related]
17. Anti-cancer peptides: classification, mechanism of action, reconstruction and modification.
Xie M; Liu D; Yang Y
Open Biol; 2020 Jul; 10(7):200004. PubMed ID: 32692959
[TBL] [Abstract][Full Text] [Related]
18. The Endocannabinoid System: A Target for Cancer Treatment.
Laezza C; Pagano C; Navarra G; Pastorino O; Proto MC; Fiore D; Piscopo C; Gazzerro P; Bifulco M
Int J Mol Sci; 2020 Jan; 21(3):. PubMed ID: 31979368
[TBL] [Abstract][Full Text] [Related]
19. Delta-like ligand 4-targeted nanomedicine for antiangiogenic cancer therapy.
Liu YR; Guan YY; Luan X; Lu Q; Wang C; Liu HJ; Gao YG; Yang SC; Dong X; Chen HZ; Fang C
Biomaterials; 2015 Feb; 42():161-71. PubMed ID: 25542804
[TBL] [Abstract][Full Text] [Related]
20. The COOH-terminal peptide of platelet factor-4 variant (CXCL4L1/PF-4var47-70) strongly inhibits angiogenesis and suppresses B16 melanoma growth in vivo.
Vandercappellen J; Liekens S; Bronckaers A; Noppen S; Ronsse I; Dillen C; Belleri M; Mitola S; Proost P; Presta M; Struyf S; Van Damme J
Mol Cancer Res; 2010 Mar; 8(3):322-34. PubMed ID: 20215425
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
